Integrated system for array-based comparative genomic hybridisation (array-CGH) brings together workstations, reagents and consumables
Genetix has launched a new, fully integrated system for array-based comparative genomic hybridisation (array-CGH).
Part of the company's cancer biology portfolio, the new approach brings together workstations, reagents and consumables for the array-CGH process.
Efficient labelling kits, automated clone pickers, flexible arraying platforms, and a high resolution scanning instrument allow users the flexibility to work with a fully integrated system.
This encompasses the entire process, from genomic DNA labelling, through to the selection and automated picking of bacterial clones, to the preparation, processing and analysis of the CGH arrays.
Importantly, Genetix says its methodology provides seamless data tracking which can combine library information with array position and signal analysis to ensure high fidelity data output.
Array-CGH has emerged as a valuable technique for analysis of the chromosomal rearrangements and DNA copy number aberrations that characterise certain disease states, including many cancers, genetic abnormalities and acquired genetic diseases.
Metaphase spread techniques have traditionally been used for this analysis but array-CGH has proven to offer dramatically improved resolution and specificity as well as significantly increased throughput.
